Trovagene Inc (TROV.OQ)

TROV.OQ on NASDAQ Stock Exchange Capital Market

4.85USD
21 Nov 2014
Price Change (% chg)

$0.03 (+0.62%)
Prev Close
$4.82
Open
$4.97
Day's High
$4.97
Day's Low
$4.83
Volume
7,638
Avg. Vol
25,414
52-wk High
$7.09
52-wk Low
$2.98

TROV.OQ

Chart for TROV.OQ

About

TrovaGene, Inc. (TrovaGene) is a development-stage molecular diagnostic company that focuses on the development and marketing of urine-based nucleic acid tests for patient/disease screening and monitoring. The Company's novel tests predominantly use transrenal DNA (Tr-DNA) and transrenal RNA (Tr-RNA). The Company's technology is... (more)

Overall

Beta: -0.28
Market Cap (Mil.): $91.11
Shares Outstanding (Mil.): 18.90
Dividend: --
Yield (%): --

Financials

  TROV.OQ Industry Sector
P/E (TTM): -- 25.90 39.20
EPS (TTM): -0.57 -- --
ROI: -37.16 7.99 17.16
ROE: -63.88 12.59 18.09
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Thomson Reuters StreetEvents
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks